Placeholder

Brand Marketing in an Era of Outcomes

$30.00

Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at mwalsh@pharmavoice.com.

SKU: 2780. Categories: , .

Product Description

    Outcomes data are increasingly ­becoming the “common currency” across stakeholder groups in healthcare. Outcomes will become much more than just a new ­marketing lever coming into play, or an ad hoc consideration of the marketing process as a whole. We believe outcomes that customers — patients, physicians, provider organizations and payers — value will become the primary ­building block of marketing strategy…

Sidebar:
OBM’s core is six integrated strategic choices designed to produce sustainable competitive advantage throughout a product’s lifecycle.

Experts
David S. Levy
, Senior Principal, IMS Consulting Group. IMS Consulting Group is the world’s leading, specialized advisor on critical business issues in life sciences. We have developed innovative analytics, with the power to link a broad range of customer data to drive unique, higher-value brand strategies. And, our groundbreaking analysis of New Commercial Models in the leading developed markets offers a comprehensive framework to help clients transform their commercial models by country and therapy area.   For more information, contact the IMS ­Consulting Group at contact.us@imscg.com.
Matthias Schneider, Engagement Manager, IMS Consulting Group. IMS Consulting Group is the world’s leading, specialized advisor on critical business issues in life sciences. We have developed innovative analytics, with the power to link a broad range of customer data to drive unique, higher-value brand strategies. And, our groundbreaking analysis of New Commercial Models in the leading developed markets offers a comprehensive framework to help clients transform their commercial models by country and therapy area.  For more information, contact the IMS ­Consulting Group at contact.us@imscg.com.
David Morris, Senior Consultant, IMS Consulting Group. IMS Consulting Group is the world’s leading, specialized advisor on critical business issues in life sciences. We have developed innovative analytics, with the power to link a broad range of customer data to drive unique, higher-value brand strategies. And, our groundbreaking analysis of New Commercial Models in the leading developed markets offers a comprehensive framework to help clients transform their commercial models by country and therapy area.   For more information, contact the IMS ­Consulting Group at contact.us@imscg.com.

FEEDBACK